Solomon Moshkevich, PRESIDENT, CLINICALDIAGNOSTICS at Natera, Inc. (NTRA), sold 3,000 shares at $217.52 ($655K) on 2026-06-01, disclosed to the SEC on 2026-06-03.
Scheduled sale ($655k) by PRESIDENT, CLINICALDIAGNOSTICS under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $217.52 | 1,802 | $392K | 59.8% |
| 2 | $218.84 | 413 | $90K | 13.8% |
| 3 | $219.34 | 213 | $47K | 7.1% |
| 4 | $220.67 | 572 | $126K | 19.3% |
| Total | $218.43 avg | 3,000 | $655K | 100% |
| Filing → |
| NTRA | SELL | 2026-08-05 | $906K | — | Filing → |
| NTRA | SELL | 2026-07-29 | $569K | — | Filing → |
| NTRA | SELL | 2026-07-06 | $819K | — | Filing → |